Evidence for developmental dopaminergic alterations in the human immunodeficiency virus-1 transgenic rat.
about
Progression of temporal processing deficits in the HIV-1 transgenic ratHIV-1 transgenic female rat: synaptodendritic alterations of medium spiny neurons in the nucleus accumbens.Neurobehavioral alterations in HIV-1 transgenic rats: evidence for dopaminergic dysfunction.Modeling deficits in attention, inhibition, and flexibility in HAND.Genetically expressed HIV-1 viral proteins attenuate nicotine-induced behavioral sensitization and alter mesocorticolimbic ERK and CREB signaling in rats.HIV-1 proteins, Tat and gp120, target the developing dopamine systemIntra-ventral tegmental area HIV-1 Tat1-86 attenuates nicotine-mediated locomotor sensitization and alters mesocorticolimbic ERK and CREB signaling in ratsImmune activation, viral gene product expression and neurotoxicity in the HIV-1 transgenic rat.Characterization of neuropathology in the HIV-1 transgenic rat at different ages.HIV-1 transgenic rats display an increase in [(3)H]dopamine uptake in the prefrontal cortex and striatum.Evolution of the HIV-1 transgenic rat: utility in assessing the progression of HIV-1-associated neurocognitive disorders.Selective developmental alterations in The HIV-1 transgenic rat: Opportunities for diagnosis of pediatric HIV-1.Imaging dopaminergic dysfunction as a surrogate marker of neuropathology in a small-animal model of HIVMR brain volumetric measurements are predictive of neurobehavioral impairment in the HIV-1 transgenic rat.Dose-dependent neurocognitive deficits following postnatal day 10 HIV-1 viral protein exposure: Relationship to hippocampal anatomy parameters.Sex Matters: Robust Sex Differences in Signal Detection in the HIV-1 Transgenic Rat.Cross-sectional and longitudinal small animal PET shows pre and post-synaptic striatal dopaminergic deficits in an animal model of HIV.Unraveling Individual Differences In The HIV-1 Transgenic Rat: Therapeutic Efficacy Of Methylphenidate.
P2860
Q30374656-53DF9195-A325-4366-AD09-B7E7295A8228Q30397434-E2598C31-9744-45C9-892D-12549C16A13AQ30445058-CBF93F01-F9A7-4C38-8F37-7438BCE0E786Q34034134-32EEB353-D11B-4C8B-B2F2-3039727C690BQ34969212-F008C1EA-0C9B-4F85-8AE7-2357277EEDE9Q35743630-7D789ADB-838D-442E-8FC4-D4C0FDB6D3B7Q35757268-CFC7E880-6C83-4C99-A0BC-F6C7817B7D5CQ35957271-DD390DB0-8E18-4542-906A-BB97748953A0Q36655192-2B6E0570-455B-4BB6-84C3-C60EF59E6225Q37672037-FF568A54-CC81-4F01-B3F7-C59D54EF0A43Q40113815-869A382E-2E28-4D4C-B8CA-8F121F37D1E0Q40570704-7C8FC61B-8842-4536-AE80-648A6B5B1D49Q41274183-F9443172-377C-43BF-B5F9-E9812F848E70Q47160714-1BA4770D-C8A0-4B20-A8F0-4E2CE0E38AC5Q47432196-190A8360-28F4-4F9E-90F0-2045554AA494Q47574273-16966B82-0072-4FD9-9D08-DB3B053B36F9Q47612809-617D2A04-1BD7-4833-9F80-680FBD1E76E0Q47873338-7D933ACB-8C86-4405-BC8D-58D4E93B64A7
P2860
Evidence for developmental dopaminergic alterations in the human immunodeficiency virus-1 transgenic rat.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Evidence for developmental dop ...... ciency virus-1 transgenic rat.
@en
Evidence for developmental dop ...... ciency virus-1 transgenic rat.
@nl
type
label
Evidence for developmental dop ...... ciency virus-1 transgenic rat.
@en
Evidence for developmental dop ...... ciency virus-1 transgenic rat.
@nl
prefLabel
Evidence for developmental dop ...... ciency virus-1 transgenic rat.
@en
Evidence for developmental dop ...... ciency virus-1 transgenic rat.
@nl
P2093
P2860
P1476
Evidence for developmental dop ...... ciency virus-1 transgenic rat.
@en
P2093
Charles F Mactutus
Katy M Webb
Michael Y Aksenov
Rosemarie M Booze
P2860
P2888
P304
P356
10.3109/13550281003690177
P577
2010-03-01T00:00:00Z
P6179
1070985848